Magnesium forms: how to choose and read the label

How magnesium forms differ in absorption, how to compare the amount of mineral per serving, and what to consider when taking medicines.

Key points

  • In small studies, citrate, aspartate, lactate and chloride were absorbed more completely than oxide and sulfate. This helps compare absorption between forms, but does not show which has a better effect on wellbeing. [1] See the evidence 1
  • On the US Supplement Facts panel, the amount refers to magnesium itself, not the total weight of the compound. Compare products by magnesium content and the number of capsules per stated serving. [1] See the evidence 1
  • Check the ingredients in a blend: the word “buffered” alone does not reveal the proportions of the forms. In one example, the label lists magnesium from a blend of bisglycinate and oxide without the proportion of each component. [1] [2] See the evidence 1 2

Practical guide

Check the conclusions and whether they apply to your situation.

The form of the compound and the amount of magnesium itself per serving help you compare supplements. We explain the label, absorption data and compatibility with medicines.

How to choose a form

Why these conclusions

Forms, absorption and labels

The names citrate, oxide and chloride refer to different magnesium compounds. In small studies, aspartate, citrate, lactate and chloride were absorbed more completely than oxide and sulfate; comparing absorption is not the same as comparing benefits for a particular goal. [1]

Elemental magnesium is the amount of the mineral itself, not the weight of the whole salt. The US Supplement Facts panel lists magnesium per serving; also check the number of capsules in that serving. For example, a tablet with 777.6 mg of glycerophosphate contains 97.2 mg of magnesium. [1] [3] [4]

In the LAC example, 556 mg of a buffered bisglycinate and oxide blend provides 100 mg of magnesium; the label does not break down the proportions of each form. Read the ingredients of other products separately. [1] [2]

Different studies used different forms and dose bases: for example, in a sleep study bisglycinate provided 250 mg of elemental magnesium daily, while 1.5 g of oxide for constipation referred to the weight of the compound. These amounts cannot be compared as equal weights of magnesium. [4] [5] [6] [7] [8] [9] [10]

If both the form and the amount are changed at once, it is impossible to tell which change affected the result. To compare, record the form, magnesium per serving and dosing schedule. [1] [3] [4]

The NIH lists magnesium oxide, citrate and chloride among supplement forms.

ParameterData
ResultThe NIH lists magnesium oxide, citrate and chloride among supplement forms.
ParticipantsGeneral information; special groups are specified separately
Formoxide, citrate, chloride
DoseNot applicable: the fact does not specify an amount or dose.
Dose basisNot applicable: the fact does not specify an amount or dose.
ComparatorNot applicable: descriptive fact, without a comparative study.
DurationNot applicable: descriptive fact; intervention duration is not assessed.
ConfidenceA numerical effectiveness rating does not apply to this reference entry.
Evidence baseNamed publications: 1
Sources[1]

In small studies, aspartate, citrate, lactate and chloride were on average absorbed more completely than oxide and sulfate; this is a comparison of bioavailability, not clinical effects.

ParameterData
ResultMore complete absorption in small studies; the size of the effect and conditions of individual studies are not provided in this excerpt.
ParticipantsGeneral information; special groups are specified separately
Formaspartate, citrate, lactate and chloride versus oxide and sulfate
DoseNot applicable: the fact does not specify an amount or dose.
Dose basisNot applicable: the fact does not specify an amount or dose.
Comparatoroxide and sulfate, according to the NIH summary
DurationNot applicable: descriptive fact; intervention duration is not assessed.
ConfidenceA numerical effectiveness rating does not apply to this reference entry.
Evidence baseNamed publications: 1
Sources[1]

The US Supplement Facts panel lists the amount of elemental magnesium, not the weight of the entire compound.

ParameterData
ResultThe US Supplement Facts panel lists the amount of elemental magnesium, not the weight of the entire compound.
ParticipantsUS dietary supplement labelling
FormNot applicable: the statement concerns magnesium or the category as a whole; the source does not specify a particular form.
DoseNot applicable: the fact does not specify an amount or dose.
Dose basisNot applicable: the fact does not specify an amount or dose.
ComparatorNot applicable: descriptive fact, without a comparative study.
DurationNot applicable: descriptive fact; intervention duration is not assessed.
ConfidenceA numerical effectiveness rating does not apply to this reference entry.
Evidence baseNamed publications: 1
Sources[1]

RDA recommendations refer to magnesium from all food, beverages, supplements and medicines, whereas the UL counts magnesium from supplements and medicines but not magnesium naturally present in food and beverages.

ParameterData
ResultRDA recommendations refer to magnesium from all food, beverages, supplements and medicines, whereas the UL counts magnesium from supplements and medicines but not magnesium naturally present in food and beverages.
ParticipantsGeneral information; special groups are specified separately
FormNot applicable: the statement concerns magnesium or the category as a whole; the source does not specify a particular form.
DoseFor adults, the UL is 350 mg/day from supplements and medicines; it is not a target dose or a universal guarantee of safety.
Dose basisFor adults, the UL is 350 mg/day from supplements and medicines; it is not a target dose or a universal guarantee of safety.
ComparatorNot applicable: descriptive fact, without a comparative study.
DurationNot applicable: descriptive fact; intervention duration is not assessed.
ConfidenceA numerical effectiveness rating does not apply to this reference entry.
Evidence baseNamed publications: 1
Sources[1]

Information from the source

NameDescriptionSources
Bisglycinate with glycineIn the sleep trial, two capsules provided 250 mg of elemental magnesium and 1,523 mg of glycine daily. The effect of glycine alone was not assessed in this trial.[4]
CitrateIn the migraine frequency study, 600 mg of elemental magnesium was used daily. This is the amount of magnesium, not the weight of the entire salt.[5]
OxideIn chronic constipation, 1.5 g of magnesium oxide daily was studied: this was the weight of the compound in a laxative regimen. Other oxide trials used different doses; the dose basis was not specified in all cases.[6]
Magtein L-threonateIn a cognitive trial, 2 g of the compound contained 145 mg of elemental magnesium daily.[7]
ChlorideIn a study of stress in people with fibromyalgia, chloride providing 100 mg of elemental magnesium daily was used. Some sports trials reported the weight of the preparation or salt, which cannot be treated as the same amount of magnesium.[8]
HydroxideIn a study of recurrent stones, doses of 650 and 1,300 mg/day refer to magnesium hydroxide as a compound; these are two doses from one trial.[9] [10]

The Supplement Facts panel lists elemental magnesium, not the weight of the compound; the source does not disclose the composition of a particular blend.

ParameterData
ResultThe Supplement Facts panel lists elemental magnesium, not the weight of the compound; the source does not disclose the composition of a particular blend.
ParticipantsUS dietary supplement labelling
FormNot applicable: the statement concerns magnesium or the category as a whole; the source does not specify a particular form.
DoseNot applicable: the fact does not specify an amount or dose.
Dose basisNot applicable: the fact does not specify an amount or dose.
ComparatorNot applicable: descriptive fact, without a comparative study.
DurationNot applicable: descriptive fact; intervention duration is not assessed.
ConfidenceA numerical effectiveness rating does not apply to this reference entry.
Evidence baseNamed publications: 1
Sources[1]

For one LAC product, the manufacturer lists 100 mg magnesium from 556 mg of a buffered bisglycinate and oxide blend; the proportions of the forms are not broken down on the label shown.

ParameterData
ResultThe total blend weight and magnesium are reported; component proportions are not given
ParticipantsA specific LAC Singapore label, without generalising to other products
FormBuffered magnesium bisglycinate and magnesium oxide according to the manufacturer
Dose100 mg magnesium per stated serving from 556 mg of the specified blend
Dose basis100 mg magnesium per stated serving from 556 mg of the specified blend
ComparatorNot applicable: a label example, not a comparative trial
DurationNot applicable: a one-time composition declaration
ConfidenceA numerical effectiveness rating does not apply to this reference entry.
Evidence baseNamed publications: 1
Sources[2]

Magnesium can reduce absorption of tetracyclines and quinolones: take the antibiotic at least 2 hours before a magnesium supplement or 4–6 hours after it.

ParameterData
ResultMagnesium can reduce absorption of tetracyclines and quinolones: take the antibiotic at least 2 hours before a magnesium supplement or 4–6 hours after it.
ParticipantsPeople taking the specified antibiotics
FormNot applicable: the statement concerns magnesium or the category as a whole; the source does not specify a particular form.
DoseNot applicable: the fact does not specify an amount or dose.
Dose basisNot applicable: the fact does not specify an amount or dose.
ComparatorNot applicable: descriptive fact, without a comparative study.
DurationTiming between doses: ≥2 hours before the supplement or 4–6 hours after
ConfidenceA numerical effectiveness rating does not apply to this reference entry.
Evidence baseNamed publications: 1
Sources[1]

Separate magnesium supplements or medicines from oral bisphosphonates by at least 2 hours to reduce the interaction.

ParameterData
ResultSeparate magnesium supplements or medicines from oral bisphosphonates by at least 2 hours to reduce the interaction.
ParticipantsPeople taking oral bisphosphonates
FormNot applicable: the statement concerns magnesium or the category as a whole; the source does not specify a particular form.
DoseNot applicable: the fact does not specify an amount or dose.
Dose basisNot applicable: the fact does not specify an amount or dose.
ComparatorNot applicable: descriptive fact, without a comparative study.
DurationAn interval of at least 2 hours
ConfidenceA numerical effectiveness rating does not apply to this reference entry.
Evidence baseNamed publications: 1
Sources[1]

In one four-week study, participants took two bisglycinate capsules 30–60 minutes before bedtime; the study did not compare dosing times.

ParameterData
ResultScheduled 30–60 minutes before bedtime; the optimal time was not established
ParticipantsAdults aged 18–65 with self-reported poor sleep; study-specific exclusion criteria
FormMagnesium bisglycinate
Dose250 mg elemental magnesium daily, 2 capsules of 125 mg each
Dose basis250 mg elemental magnesium daily, 2 capsules of 125 mg each
ComparatorCellulose placebo; dosing times were not compared between groups
Duration4 weeks
ConfidenceA numerical effectiveness rating does not apply to this reference entry.
Evidence baseNamed publications: 1
Sources[4]

Instructions for a specific medicinal magnesium glycerophosphate product require tablets to be chewed and the doctor’s directions followed; this medicine’s regimen cannot be applied to all supplements.

ParameterData
ResultChew before swallowing; product instructions, not a general supplement regimen
ParticipantsPatients prescribed these tablets; the instructions address children and impaired kidney function separately
FormMedicinal magnesium glycerophosphate
DosePer tablet: 4 mmol (97.2 mg) magnesium from 777.6 mg glycerophosphate; individual prescription by a doctor
Dose basisPer tablet: 4 mmol (97.2 mg) magnesium from 777.6 mg glycerophosphate; individual prescription by a doctor
ComparatorNot applicable: medicine instructions, not a comparative trial
DurationDuration depends on the prescription; no universal duration is specified
ConfidenceA numerical effectiveness rating does not apply to this reference entry.
Evidence baseNamed publications: 1
Sources[3]

Different magnesium forms are absorbed differently; when comparing amounts on the US Supplement Facts panel, use elemental magnesium rather than the weight of the compound.

ParameterData
ResultCharacteristics that can be checked for comparison, not proof of the cause of a change
ParticipantsGeneral information; special groups are specified separately
FormNot applicable: the statement concerns magnesium or the category as a whole; the source does not specify a particular form.
DoseNot applicable: the fact does not specify an amount or dose.
Dose basisNot applicable: the fact does not specify an amount or dose.
ComparatorNot applicable: descriptive fact, without a comparative study.
DurationNot applicable: descriptive fact; intervention duration is not assessed.
ConfidenceA numerical effectiveness rating does not apply to this reference entry.
Evidence baseNamed publications: 1
Sources[1]

In two examples, sources list compound weight and magnesium separately: 777.6 mg glycerophosphate contains 97.2 mg magnesium per tablet; in a trial a capsule contained 893 mg bisglycinate and 125 mg magnesium.

ParameterData
ResultCompound weight and magnesium weight differ
ParticipantsA specific medicinal tablet
FormMagnesium glycerophosphate
Dose777.6 mg of compound and 97.2 mg magnesium per tablet
Dose basis777.6 mg of compound and 97.2 mg magnesium per tablet
ComparatorNot applicable: declaration for a specific product
DurationNot applicable: composition of one tablet
ConfidenceA numerical effectiveness rating does not apply to this reference entry.
Evidence baseNamed publications: 2
Sources[3] [4]

More details

Amount and compatibility with medicines

For adults, the tolerable upper intake level is 350 mg magnesium daily from supplements and medicines; it excludes magnesium naturally present in food and beverages. The recommended dietary allowance (RDA), by contrast, covers all sources together. [1]

Magnesium can reduce absorption of tetracyclines and quinolones: take the antibiotic at least 2 hours before the supplement or 4–6 hours after it. Separate magnesium supplements and medicines from oral bisphosphonates by at least 2 hours. [1]

In the sleep study, bisglycinate was taken 30–60 minutes before bedtime, but dosing times were not compared. Instructions to chew a specific medicinal glycerophosphate tablet apply to that product and do not set a regimen for all supplements. [4] [3]

Sources

  1. Magnesium: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/
  2. Albion™ Magnesium Bisglycinate. https://www.lac.sg/en/vitamins-and-supplements_minerals_magnesium/lac-minerals/albion-magnesium-bisglycinate-01406590.html?catId=promotions-limited-time-mailer-2
  3. Magnesium 4mmol Chewable Tablets - Patient Information Leaflet. https://www.medicines.org.uk/emc/product/11577/pil
  4. Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial. https://pubmed.ncbi.nlm.nih.gov/40918053/
  5. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. https://pubmed.ncbi.nlm.nih.gov/8792038/
  6. The effect of food, vitamin, or mineral supplements on chronic constipation in adults: A systematic review and meta-analysis of randomized controlled trials. https://pubmed.ncbi.nlm.nih.gov/37243443/
  7. The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial. https://doi.org/10.3389/fnut.2025.1729164
  8. Short-Term Magnesium Therapy Alleviates Moderate Stress in Patients with Fibromyalgia: A Randomized Double-Blind Clinical Trial. https://pubmed.ncbi.nlm.nih.gov/35631229/
  9. Results. https://www.ncbi.nlm.nih.gov/books/NBK621670/
  10. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. https://pubmed.ncbi.nlm.nih.gov/3280829/

Methodology: Subpages evidence-led supplement pipeline v1

Ingredient overview: Magnesium